Why the study?
ROS contribute to myocardial death during ischemia-reperfusion injury, but detailed knowledge of the molecular pathways connecting ROS to cardiac injury is lacking.
Population
Mice and isolated ventricular myocytes
Comparison
MMVV mice resistant to CaMKIIδ ROS activation vs WT controls
Design
In vivo and in vitro animal experiment
Follow-up
24 hours
Key result
Mice with a knock-in mutation making CaMKIIδ resistant to reactive oxygen species activation (MMVV) exhibited significantly reduced myocardial death and improved left ventricular function 24 hours after ischemia-reperfusion injury compared to wild-type controls.
Authors
Loading...
Ox-CaMKIIδ inhibition may confer cardioprotection; leaves open translation from mice to human ischemia-reperfusion injury.
p-value: p=<0.05
Preventing CaMKIIδ oxidation protects against ischemia-reperfusion injury by preserving KATP channel current, identifying ox-CaMKII as a key mediator of ROS-induced myocardial death.
Wu et al. (2019) studied Myocardial ischemia-reperfusion injury. CaMKIIδ oxidation resistance (MMVV knock-in mutation) vs. Wild-type (WT) mice was evaluated on Myocardial death (Area of necrosis / Area at risk) after I/R injury (p=<0.05). Mice with a knock-in mutation making CaMKIIδ resistant to reactive oxygen species activation (MMVV) exhibited significantly reduced myocardial death and improved left ventricular function 24 hours after ischemia-reperfusion injury compared to wild-type controls.